MedTrace Logo

Adaptive Servo-Ventilation in "Real Life" Conditions : the OTRLASV Study

NCT02429986 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2020-09-25

No results posted yet for this study

Summary

Adaptive Servo-Ventilation (ASV) treatment is routinely prescribed in France. In order to be reimbursed according to the French Social Security rules, the patient treated with an ASV needs to be examined each year. In this observational transversal single-visit study, the investigators aim to describe the clinical characteristics of patients treated with ASV and the associated device settings.

Conditions

  • Chronic Heart Failure and
  • Complex Sleep Apnea Syndrome
  • Obstructive Sleep Apnea Syndrome and
  • Idiopathic Central Sleep Apnea Syndrome
  • Idiopathic Induced Periodic Breathing
  • Central Sleep Apnea Syndrome

Interventions

DEVICE

Adaptive Servo-Ventilation

Adaptive Servo-Ventilation proceeds by continually measuring either minute ventilation or airflow and calculates a target ventilation to be applied as needed.

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Dany JAFFUEL, MD, PhD · Polyclinic Saint-Privat

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-13
Primary Completion
2017-01-17
Completion
2017-01-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02429986 on ClinicalTrials.gov